Ipragliflozin

未知生产厂商

Ipragliflozin is under investigation in Type 2 Diabetes and Diabetes Mellitus, Type 2.

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Ipragliflozin is under investigation in Type 2 Diabetes and Diabetes Mellitus, Type 2.

技术标识符

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Ipragliflozin composition
申请人: WEIHAI GUANBIAO INFORMATION TECH CO LTD优先权: 2017
CN
Synthetic method of Ipragliflozin
申请人: UNIV DALIAN TECH优先权: 2016
CN
Preparation method of ipragliflozin
申请人: SHANGHAI INST PHARMACEUTICAL IND优先权: 2015
CN
Ipragliflozin new crystal form
申请人: WEIHAI GUANBIAO INFORMATION TECH CO LTD优先权: 2018
CN
Method for synthesizing ipragliflozin
申请人: ANQING CHICO PHARMACEUTICAL CO LTD优先权: 2018
CN
Ipragliflozin L-proline tablet composition
申请人: WEIHAI GUANBIAO INFORMATION TECH CO LTD优先权: 2017
CN
Ipragliflozin L-proline tablet composition
申请人: WEIHAI GUANBIAO INFORMATION TECH CO LTD优先权: 2017
CN
Ipragliflozin L-proline tablet composition
申请人: WEIHAI GUANBIAO INFORMATION TECH CO LTD优先权: 2017
CN